George Mason University HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects The funding is being provided to 10 groups through the LymeX Diagnostics Prize initiative, which was launched in late 2020 by theHHS- and Cohen Foundation-backed Lyme Innovation Accelerator. Theralink Partners With George Mason, Rutgers Cancer Institute on Breast Cancer Test The test, developed at George Mason, measures HER2 activation in a breast cancer biopsy to help determine if a patient will respond to treatment. Fluidigm CEO Lays Out Plan for 'Durable' Diagnostics, Clinical Business Post-COVID Premium Fluidigm CEO Chris Linthwaite said the company aims to further penetrate the diagnostic and clinical markets with both its microfluidics and mass cytometry businesses. Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth The firm also announced a COVID-19 testing deal with George Mason University and a CyTOF supply and distribution agreement with Zhejiang PuLuoTing Health Technology in China. Inova, George Mason Partner to Create Proteomics Center The partners will work together on personalized medicine research at several new centers in the Northern Virginia area. May 6, 2014 TGen, George Mason Launch Precision Medicine Alliance May 2, 2012 BGI Partners with US Researchers to Sequence 100 Human Adenoviruses Jun 14, 2011 IP Roundup: Jun 14, 2011 Premium Oct 22, 2010 Despite MRM-MS's Promise as a Clinical Platform, Technical Hurdles and High Costs Remain Problematic Premium Mar 26, 2010 GMU’s Reverse-phase Protein Microarray Technology Included in I-SPY2 Breast Cancer Trial Premium Mar 26, 2010 Thermo Fisher Extends Collaborations to Validate Protein Biomarkers, Build SRM-based Assays Premium Mar 24, 2010 Thermo Fisher Extends Biomarker Pact with Universities Mar 12, 2010 Clinical Trial Using Proteomics Technologies for Personalized Medicine Approach to Breast Cancer Premium Jan 20, 2010 GMU Developing Proteomic Profile to Personalize Gleevec Treatment for CRC; Novartis Provides Funding Premium Feb 18, 2009 Survey of Tech-Transfer Offices Reveals Typical Motivators; AUTM Panel Weighs Various Models Premium Breaking News Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Metastatic Tumor Subtypes Found With Expression Profiling GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.